News
| 3 min read
Data presented at the American Heart Association’s International Stroke Conference highlight a potential shift in stroke prevention.
| 6 min read
With multiple trials underway and billions in investment, psychedelic therapies are moving from experimental research toward mainstream mental health care.
| 5 min read
Automation, digital manufacturing, and regulatory reform are reshaping how the UK competes in cell and gene therapy as the field moves toward routine delivery.
| 4 min read
These late-stage therapies span obesity, diabetes, hypertension, and allergy care, offering new mechanisms and delivery formats that could reshape patient treatment.
| 3 min read
Multi-omics analysis reveals a nine-gene signature linked to treatment failure in aggressive tumor behavior.
| 4 min read
By explicitly specifying treatment effects and intercurrent events, estimands help sponsors, clinicians, and regulators work from a shared understanding.
| 5 min read
After decades of slow progress, advances in molecular profiling and organoid technology are creating new pathways for non-invasive diagnosis and targeted treatment of endometriosis.
| 3 min read
Direct evidence of cardiomyocyte division in living human tissue reframes long-held assumptions about cardiac irreversibility, while underscoring how far therapies still have to go.
| 4 min read
Neuroscience discoveries, pharma investments, FOIA requests, and more led the news this week.
| 5 min read
What commercialization looks like when headcount shrinks, launches can’t miss, and geography becomes a risk decision.
| 4 min read
A new CAR T therapy targets the immune cells that protect tumors, reshaping the tumor microenvironment and enabling host immune clearance.
| 5 min read
Studies indicate AI-enabled compound management systems can streamline workflows, reduce manual errors, and provide better visibility into experimental and predicted data.
